New injection shows promise for smoothing frown lines and Crow's feet
NCT ID NCT05148000
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a new injection called QM1114-DP in 25 adults with moderate to severe frown lines and crow's feet. Participants received one treatment and were asked to rate how much their appearance improved. The goal was to see if the treatment could make these wrinkles look better.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- QM1114-DP (a botulinum toxin type A injection)
- What this could lead to
- If successful, this could provide a new option for temporarily reducing the appearance of frown lines and crow's feet.
- What could go wrong
- This is a small, completed Phase 3 study with only 25 participants. Results may not apply to everyone, and effects are temporary. Allergic reactions or bruising at injection site are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANTHAL LINES are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Galderma Research Site
New York, New York, 10021, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which wrinkle treatment lasts longest? Head-to-Head trial of all five botox products
- Nuceiva safety checked in 756 patients for frown lines
- Botox breakthrough? study tests if injection depth matters for wrinkle treatment
- Botox study shows promise for smoothing upper face wrinkles
- New wrinkle treatment takes on botox in major trial